First Header Logo Second Header Logo

Search Results (7)

More Search Options
MatchTypeWhy
Aromatase inhibitors increase the sensitivity of human tumor cells to monocyte-mediated, antibody-dependent cellular cytotoxicity.Academic Article Why?
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors.Academic Article Why?
Aromatase InhibitorsConcept Why?
Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network.Academic Article Why?
A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast cancer after aromatase inhibitor (AI) failure.Academic Article Why?
Aromatase inhibition causes increased amplitude, but not frequency, of hypothalamic-pituitary output in normal women.Academic Article Why?
Aromatase inhibitor plus ovarian suppression as adjuvant therapy in premenopausal women with breast cancer.Academic Article Why?
Endometrial receptivity defects during IVF cycles with and without letrozole.Academic Article Why?
Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer.Academic Article Why?
Myocardial Function in Premenopausal Women Treated With Ovarian Function Suppression and an Aromatase Inhibitor.Academic Article Why?
Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study.Academic Article Why?
Lessey, BrucePerson Why?
Dressler, EmilyPerson Why?
Breast cancer treatment in older women.Academic Article Why?
Does postmenopausal estrogen use confer neuroprotection?Academic Article Why?
Per Page    Page  of 1
Next
Prev
Search Criteria
  • Aromatase Inhibitors
Filter by Type
_
Click "Why?" to see why an item matched the search.